Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Has results
×
ridaforolimus
×
Clear all
Filters
3
NCT01605396
2019-03-25
MK-8669-064
Merck Sharp & Dohme LLC
Phase 2
Completed
80 enrolled
13 charts
NCT00836927
2019-02-18
MK-8669-038
Merck Sharp & Dohme LLC
Phase 2
Terminated
7 enrolled
13 charts